UNSPSC 85891803: High dose rate (hdr) brachytherapy of adrenal glands using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of adrenal glands using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DG129BZ

UNSPSC 85891803 High dose rate (hdr) brachytherapy of adrenal glands using palladium 103 (pd-103) is a Commodity code that shows no relevant recent state and local procurement activity. The single opportunity posted under this code — County of Santa Clara Health System RFSQHHSFY270052, due October 7, 2026 — solicits temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, and therapy services, which falls outside the scope of the code's nominal designation as a specialized cancer treatment procedure using radioactive palladium implants.

The mismatch between the code's specificity and the actual work being purchased suggests either a miscoding error in the Santa Clara County Health System's procurement notice or minimal routine market activity for this particular brachytherapy modality in state and local procurement channels. State and local governments rarely solicit highly specialized oncology procedures as commodity-level goods; such services are typically procured through health system contracts negotiated at the organizational level or classified under broader clinical staffing or equipment categories. Business development professionals targeting this code should verify the actual UNSPSC classification of relevant opportunities and monitor broader health professional staffing and clinical equipment families for related purchasing patterns.